The management of post-herpetic neuralgiaBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7264.778 (Published 30 September 2000) Cite this as: BMJ 2000;321:778
If early treatment fails, patients should be referred to pain clinics
- Anthony L Cunningham, director (Tony_cunningham@wmi.usyd.edu.au),
- Robert H Dworkin, director (email@example.com)
- Westmead Millennium Institute, Westmead, NSW 2145, Australia
- Center for Analgesic Research, University of Rochester School of Medicine and Dentistry, 2337 South Clinton Avenue, Rochester, NY 14618, USA
General practice p 794
Shingles, or herpes zoster, may occur at any stage in a person's life. Herpes zoster is the clinical manifestation of the reactivation of a lifelong latent infection with varicella zoster virus, usually contracted after an episode of chickenpox in early life.1 Varicella zoster virus tends to be reactivated only once in a lifetime, with the incidence of second attacks being <5%.2 Herpes zoster occurs more commonly in later life (as T cell immunity to the virus wanes) and in patients who have T cell immunosuppression.
Pain persisting after herpes zoster, termed post-herpetic neuralgia, is the commonest and most feared complication. Its definition is controversial, ranging from pain persisting after the rash heals to pain persisting 30 days or 6 months after the onset of herpes zoster. Some experts consider all pain during and after herpes zoster as a continuum. Therefore we have suggested that this total duration of pain and pain at a single time point (3 months after onset) be used as endpoints in clinical studies.3 Post-herpetic neuralgia is associated with scarring of the dorsal root ganglion and atrophy of the dorsal horn on the affected side, which follows the extensive inflammation that occurs during herpes zoster. These and other abnormalities of the peripheral and central …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.